EE03471B1 - Dopamiini agonisti sisaldav farmatseutiline kompositsioon, selle kasutamine ja valmistamismeetod, farmatseutiline produkt ja komplekt ning antatsiidi kasutamine - Google Patents

Dopamiini agonisti sisaldav farmatseutiline kompositsioon, selle kasutamine ja valmistamismeetod, farmatseutiline produkt ja komplekt ning antatsiidi kasutamine

Info

Publication number
EE03471B1
EE03471B1 EE9800050A EE9800050A EE03471B1 EE 03471 B1 EE03471 B1 EE 03471B1 EE 9800050 A EE9800050 A EE 9800050A EE 9800050 A EE9800050 A EE 9800050A EE 03471 B1 EE03471 B1 EE 03471B1
Authority
EE
Estonia
Prior art keywords
active ingredient
dopamine agonist
composition
pharmaceutical composition
antacid
Prior art date
Application number
EE9800050A
Other languages
English (en)
Estonian (et)
Other versions
EE9800050A (et
Inventor
Stewart Johnson Edward
David Green Richard
Clarke Anthony
Original Assignee
R.P. Scherer Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by R.P. Scherer Limited filed Critical R.P. Scherer Limited
Publication of EE9800050A publication Critical patent/EE9800050A/xx
Publication of EE03471B1 publication Critical patent/EE03471B1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/485—Morphinan derivatives, e.g. morphine, codeine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
EE9800050A 1995-08-18 1996-08-16 Dopamiini agonisti sisaldav farmatseutiline kompositsioon, selle kasutamine ja valmistamismeetod, farmatseutiline produkt ja komplekt ning antatsiidi kasutamine EE03471B1 (et)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9517062.7A GB9517062D0 (en) 1995-08-18 1995-08-18 Pharmaceutical compositions
PCT/GB1996/002020 WO1997006786A1 (en) 1995-08-18 1996-08-16 Oral fast-dissolving compositions for dopamine agonists

Publications (2)

Publication Number Publication Date
EE9800050A EE9800050A (et) 1998-08-17
EE03471B1 true EE03471B1 (et) 2001-08-15

Family

ID=10779521

Family Applications (1)

Application Number Title Priority Date Filing Date
EE9800050A EE03471B1 (et) 1995-08-18 1996-08-16 Dopamiini agonisti sisaldav farmatseutiline kompositsioon, selle kasutamine ja valmistamismeetod, farmatseutiline produkt ja komplekt ning antatsiidi kasutamine

Country Status (27)

Country Link
US (1) US6316027B1 (es)
EP (1) EP0850050B1 (es)
JP (1) JPH11511162A (es)
AT (1) ATE196249T1 (es)
AU (1) AU709641B2 (es)
BG (1) BG63188B1 (es)
BR (1) BR9610424A (es)
CA (1) CA2229597C (es)
CZ (1) CZ293129B6 (es)
DE (1) DE69610323T2 (es)
DK (1) DK0850050T3 (es)
EE (1) EE03471B1 (es)
ES (1) ES2151672T3 (es)
GB (1) GB9517062D0 (es)
GR (1) GR3034583T3 (es)
HU (1) HU222197B1 (es)
MX (1) MX9801305A (es)
NO (1) NO313368B1 (es)
NZ (1) NZ315740A (es)
PL (1) PL187718B1 (es)
PT (1) PT850050E (es)
RO (1) RO119066B1 (es)
RU (1) RU2189226C2 (es)
SK (1) SK283597B6 (es)
UA (1) UA64700C2 (es)
WO (1) WO1997006786A1 (es)
ZA (1) ZA967032B (es)

Families Citing this family (145)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6121276A (en) * 1994-04-22 2000-09-19 Pentech Pharmaceuticals, Inc. Apomorphine-containing dosage forms for ameliorating male erectile dysfunction
US5888534A (en) * 1995-06-13 1999-03-30 Pentech Pharmaceuticals, Inc. Controlled release of drugs delivered by sublingual or buccal administration
GB9517062D0 (en) 1995-08-18 1995-10-25 Scherer Ltd R P Pharmaceutical compositions
GB9700878D0 (en) 1997-01-17 1997-03-05 Scherer Ltd R P Dosage forms and method for ameliorating male erectile dysfunction
US20040023948A1 (en) * 1997-03-24 2004-02-05 Green Richard David Fast-dispersing dosage form containing 5-HT1 agonists
ATE333279T1 (de) * 1997-05-19 2006-08-15 Zonagen Inc Kombinationstherapie zur modulation der humanen sexualreaktion
JP2002507982A (ja) 1997-07-01 2002-03-12 イムプリコ ベスローテン フェンノートシャップ 迅速な放出性の組成物
US20030118645A1 (en) * 1998-04-29 2003-06-26 Pather S. Indiran Pharmaceutical compositions for rectal and vaginal administration
US20030091629A1 (en) 1998-03-27 2003-05-15 Cima Labs Inc. Sublingual buccal effervescent
US6974590B2 (en) 1998-03-27 2005-12-13 Cima Labs Inc. Sublingual buccal effervescent
GB9904911D0 (en) * 1999-03-03 1999-04-28 Scherer Ltd R P Pharmaceutical compositions
GB9908014D0 (en) * 1999-04-08 1999-06-02 Scherer Corp R P Pharmaceutical compositions
CZ20022245A3 (cs) * 1999-12-30 2002-10-16 Tap Holdings, Inc. Orální mukózní dávkovací formy apomorfinu
CA2418915A1 (en) * 2000-08-08 2002-02-14 Teva Pharmaceutical Industries Ltd. Stable pergolide mesylate and process for making same
NZ524741A (en) * 2000-08-16 2005-01-28 Upjohn Co Heterocyclic amines, phenylazacycloalkanes, cabergoline and aromatic bicyclic amines for the treatment of alcohol, nicotine and drug addiction
SE0102036D0 (sv) * 2001-06-08 2001-06-08 Axon Biochemicals Bv Pharmaceutical formulation for the efficient administration of apomorphine, 6aR- (-) -N- Propyl- norapomorphine and their derivatives and pro-drugs thereof
SE0002934D0 (sv) 2000-08-17 2000-08-17 Axon Biochemicals Bv New aporphine esters and in their use in therapy
DE10107659B4 (de) * 2001-02-19 2008-03-13 Lts Lohmann Therapie-Systeme Ag Mucoadhäsive zerfallsfähige Arzneizubereitung zur Wirkstoffverabreichung in der Veterinär- und Humanmedizin
US20030068356A1 (en) * 2001-07-10 2003-04-10 Pather S. Indiran Sequential drug delivery systems
FR2834894B1 (fr) * 2002-01-21 2004-02-27 Servier Lab Composition pharmaceutique orodispersible de piribedil
EP1487460A2 (en) 2002-02-28 2004-12-22 A & D Bioscience, Inc. Glycuronamides, glycosides and orthoester glycosides of fluoxetine, analogs and uses thereof
WO2003079980A2 (en) * 2002-03-19 2003-10-02 A & D Bioscience, Inc. Caboxylic acid glycuronides, glycosamides and glycosides of quinolones, penicillins, analogs, and uses thereof
US20060004190A1 (en) * 2002-03-19 2006-01-05 Michael Holick Glycoside and orthoester glycoside derivatives of apomorphine, analogs, and uses thereof
CA2478523A1 (en) 2002-04-05 2003-10-16 Euro-Celtique S.A. Matrix for sustained, invariant and independent release of active compounds
US20050255038A1 (en) * 2002-04-12 2005-11-17 A And D Bioscience, Inc. Conjugates comprising cancer cell specific ligands, a sugar and diagnostic agents and uses thereof
WO2003092591A2 (en) * 2002-04-30 2003-11-13 Npd Llc Multi-phasic delivery via transmucosal absorption of antiemetic medicaments
WO2003094842A2 (en) * 2002-05-07 2003-11-20 A & D Bioscience, Inc. Conjugates comprising central nervous system active drug
US20040029843A1 (en) * 2002-06-20 2004-02-12 Orapharma, Inc. Rapidly disintegrating formulations for treating or preventing mucositis
US20050215487A1 (en) * 2002-06-27 2005-09-29 Holick Michael F Conjugates comprising an nsaid and a sugar and uses thereof
GB0217056D0 (en) * 2002-07-23 2002-08-28 Ass Octel Use
US8821915B2 (en) 2002-08-09 2014-09-02 Veroscience, Llc Therapeutic process for the treatment of the metabolic syndrome and associated metabolic disorders
GB0226076D0 (en) * 2002-11-08 2002-12-18 Rp Scherer Technologies Inc Improved formulations containing substituted imidazole derivatives
US20040156894A1 (en) * 2003-02-07 2004-08-12 Grother Leon Paul Use of edible acids in fast-dispersing pharmaceutical solid dosage forms
SI2316456T1 (sl) 2003-04-29 2017-10-30 Orexigen Therapeutics, Inc. Sestavki za vplivanje na izgubo teže, ki obsegajo opioidni antagonist in bupropion
US7862833B2 (en) * 2003-12-31 2011-01-04 Cima Labs, Inc. Effervescent oral opiate dosage forms and methods of administering opiates
NZ548216A (en) * 2003-12-31 2010-02-26 Cima Labs Inc Generally linear effervescent oral fentanyl dosage form and methods of administering
WO2005065317A2 (en) 2003-12-31 2005-07-21 Cima Labs Inc. Effervescent oral fentanyl dosage form
US7576073B2 (en) 2004-05-28 2009-08-18 UNIVERSITé LAVAL Combined therapy for the treatment of parkinson's disease
WO2006096194A2 (en) * 2004-06-17 2006-09-14 Merz Pharma Gmbh & Co. Kgaa Drinkable immediate release tablet made with direct compression of memantine or neramexane
CA2628298A1 (en) * 2004-11-03 2006-05-11 Clera Inc. Method to detect dopamine receptors in the functional d2high state
JP2008534563A (ja) * 2005-03-28 2008-08-28 オレクソ・アクチエボラゲット パーキンソン病の治療に有用な新しい製薬組成物
GB0509317D0 (en) * 2005-05-06 2005-06-15 Clarke Anthony Pharmaceutical formulation of apomorphine
US20070128285A1 (en) * 2005-07-12 2007-06-07 Chikara Jin Pharmaceutical composition for oral administration
US20070020186A1 (en) 2005-07-22 2007-01-25 Alpex Pharma S.A. Solid dosage formulations of narcotic drugs having improved buccal adsorption
US20070105867A1 (en) * 2005-09-21 2007-05-10 Bristol-Myers Squibb Company Oral administration of N-(2-chloro-6-methylphenyl)-2-[[6-[4-(2-hydroxyethyl)-1-piperazinyl]-2-methyl-4-pyrimidinyl]amino]-1,3-thiazole-5-carboxamide and salts thereof
EP2135603B1 (en) 2005-11-22 2013-01-02 Orexigen Therapeutics, Inc. Compositions and methods for increasing insulin sensitivity
US8916195B2 (en) 2006-06-05 2014-12-23 Orexigen Therapeutics, Inc. Sustained release formulation of naltrexone
WO2007147133A1 (en) * 2006-06-15 2007-12-21 Serenex, Inc. Stabilized tetracycline compositions
DE102006027793A1 (de) * 2006-06-16 2007-12-20 Lts Lohmann Therapie-Systeme Ag Opioid-Kombinations-Wafer
US20080014228A1 (en) * 2006-07-14 2008-01-17 Olivia Darmuzey Solid form
EP1897543A1 (en) 2006-08-30 2008-03-12 Euro-Celtique S.A. Buprenorphine- wafer for drug substitution therapy
KR20150082689A (ko) 2006-11-09 2015-07-15 오렉시젠 세러퓨틱스 인크. 단위 용량 팩키지
US20080311162A1 (en) * 2007-05-16 2008-12-18 Olivia Darmuzey Solid form
US20100035886A1 (en) 2007-06-21 2010-02-11 Veroscience, Llc Parenteral formulations of dopamine agonists
US8741918B2 (en) 2007-06-21 2014-06-03 Veroscience Llc Parenteral formulations of dopamine agonists
US20110111014A1 (en) * 2007-06-26 2011-05-12 Parkinson's Institute Methods and compositions for treatment of neurological disorders
US20090004248A1 (en) * 2007-06-29 2009-01-01 Frank Bunick Dual portion dosage lozenge form
US20090004231A1 (en) 2007-06-30 2009-01-01 Popp Shane M Pharmaceutical dosage forms fabricated with nanomaterials for quality monitoring
CA2725930A1 (en) 2008-05-30 2009-12-30 Orexigen Therapeutics, Inc. Methods for treating visceral fat conditions
WO2010019856A1 (en) * 2008-08-15 2010-02-18 The Mclean Hospital Corporation Methods and kits for treatings stroke and other neurological conditions
DE102009036285A1 (de) * 2008-10-13 2010-04-15 Illinois Tool Works Inc., Glenview Verfahren zur Herstellung eines Bohrers, insbesondere eines Gesteinsbohrers
US20100116281A1 (en) 2008-11-07 2010-05-13 Jerry Wayne Marshall Tobacco products and processes
US9352025B2 (en) 2009-06-05 2016-05-31 Veroscience Llc Combination of dopamine agonists plus first phase insulin secretagogues for the treatment of metabolic disorders
ES2699077T3 (es) 2009-06-12 2019-02-07 Sunovion Pharmaceuticals Inc Apomorfina sublingual
US8545879B2 (en) 2009-08-31 2013-10-01 Wilmington Pharmaceuticals, Llc Fast disintegrating compositions of meloxicam
CA2940931C (en) 2009-10-01 2019-04-30 Adare Pharmaceuticals, Inc. Orally administered corticosteroid compositions
TR201902233T4 (tr) 2009-10-30 2019-03-21 Ix Biopharma Ltd Hızlı çözünen katı dozaj formu.
CN102724878A (zh) 2010-01-11 2012-10-10 奥雷西根治疗公司 在重度抑郁症患者中提供体重减轻疗法的方法
US9675102B2 (en) 2010-09-07 2017-06-13 R. J. Reynolds Tobacco Company Smokeless tobacco product comprising effervescent composition
AR083361A1 (es) * 2010-10-08 2013-02-21 Scherer Technologies Inc R P Forma de dosificacion de rapida disolucion de vacuna oral utilizando almidon
NZ612686A (en) 2010-12-16 2015-11-27 Cynapsus Therapeutics Inc Sublingual films
US10881132B2 (en) 2011-12-14 2021-01-05 R.J. Reynolds Tobacco Company Smokeless tobacco product comprising effervescent composition
DK3730132T3 (da) 2012-06-06 2022-08-08 Nalpropion Pharmaceuticals Llc Sammensætning til anvendelse ved en fremgangsmåde til behandling af overvægt og obesitas hos patienter med høj kardiovaskulær risiko
CN110506995B (zh) 2013-03-15 2022-07-01 R·J·雷诺兹烟草公司 由材料的薄片形成的加热元件
WO2015034678A2 (en) 2013-09-06 2015-03-12 Aptalis Pharmatech, Inc. Corticosteroid containing orally disintegrating tablet compositions for eosinophilic esophagitis
EP3068396B1 (en) * 2013-11-11 2019-05-08 Impax Laboratories, Inc. Rapidly disintegrating formulations and methods of use
US8969371B1 (en) 2013-12-06 2015-03-03 Orexigen Therapeutics, Inc. Compositions and methods for weight loss in at risk patient populations
EP3285771A4 (en) 2015-04-21 2018-12-05 Sunovion Pharmaceuticals Inc. Methods of treating parkinson's disease by administration of apomorphine to an oral mucosa
US10611505B2 (en) 2015-05-04 2020-04-07 Rai Strategic Holdings, Inc. Dispensing machine for aerosol precursor
US10238145B2 (en) 2015-05-19 2019-03-26 Rai Strategic Holdings, Inc. Assembly substation for assembling a cartridge for a smoking article
US20170112194A1 (en) 2015-10-21 2017-04-27 Rai Strategic Holdings, Inc. Rechargeable lithium-ion capacitor for an aerosol delivery device
US10820630B2 (en) 2015-11-06 2020-11-03 Rai Strategic Holdings, Inc. Aerosol delivery device including a wirelessly-heated atomizer and related method
US10104912B2 (en) 2016-01-20 2018-10-23 Rai Strategic Holdings, Inc. Control for an induction-based aerosol delivery device
US11207478B2 (en) 2016-03-25 2021-12-28 Rai Strategic Holdings, Inc. Aerosol production assembly including surface with micro-pattern
US10334880B2 (en) 2016-03-25 2019-07-02 Rai Strategic Holdings, Inc. Aerosol delivery device including connector comprising extension and receptacle
US10405579B2 (en) 2016-04-29 2019-09-10 Rai Strategic Holdings, Inc. Methods for assembling a cartridge for an aerosol delivery device, and associated systems and apparatuses
US11019847B2 (en) 2016-07-28 2021-06-01 Rai Strategic Holdings, Inc. Aerosol delivery devices including a selector and related methods
TWI777515B (zh) 2016-08-18 2022-09-11 美商愛戴爾製藥股份有限公司 治療嗜伊紅性食道炎之方法
US10477896B2 (en) 2016-10-12 2019-11-19 Rai Strategic Holdings, Inc. Photodetector for measuring aerosol precursor composition in an aerosol delivery device
US20180132528A1 (en) 2016-11-14 2018-05-17 Rai Strategic Holdings, Inc. Photoelectric proximity sensor for gesture-based control of an aerosol delivery device
US20180132529A1 (en) 2016-11-14 2018-05-17 Rai Strategic Holdings, Inc. Aerosol delivery device with integrated wireless connectivity for temperature monitoring
US10524508B2 (en) 2016-11-15 2020-01-07 Rai Strategic Holdings, Inc. Induction-based aerosol delivery device
US10537137B2 (en) 2016-11-22 2020-01-21 Rai Strategic Holdings, Inc. Rechargeable lithium-ion battery for an aerosol delivery device
JP7110194B2 (ja) 2016-12-01 2022-08-01 アール・エイ・アイ・ストラテジック・ホールディングス・インコーポレイテッド エアロゾル送達装置用の再充電可能なリチウムイオンキャパシタ
CA3045081A1 (en) 2016-12-02 2018-06-07 Rai Strategic Holdings, Inc. Induction charging for an aerosol delivery device
US11013266B2 (en) 2016-12-09 2021-05-25 Rai Strategic Holdings, Inc. Aerosol delivery device sensory system including an infrared sensor and related method
US10517326B2 (en) 2017-01-27 2019-12-31 Rai Strategic Holdings, Inc. Secondary battery for an aerosol delivery device
US10759554B2 (en) 2017-02-02 2020-09-01 Rai Strategic Holdings, Inc. Dispenser unit for aerosol precursor
US10827783B2 (en) 2017-02-27 2020-11-10 Rai Strategic Holdings, Inc. Digital compass for an aerosol delivery device
US10314340B2 (en) 2017-04-21 2019-06-11 Rai Strategic Holdings, Inc. Refillable aerosol delivery device and related method
US11297876B2 (en) 2017-05-17 2022-04-12 Rai Strategic Holdings, Inc. Aerosol delivery device
US10517330B2 (en) 2017-05-23 2019-12-31 RAI Stategic Holdings, Inc. Heart rate monitor for an aerosol delivery device
US10349674B2 (en) 2017-07-17 2019-07-16 Rai Strategic Holdings, Inc. No-heat, no-burn smoking article
US11337456B2 (en) 2017-07-17 2022-05-24 Rai Strategic Holdings, Inc. Video analytics camera system for an aerosol delivery device
US10791761B2 (en) 2017-08-17 2020-10-06 Rai Strategic Holdings, Inc. Microtextured liquid transport element for aerosol delivery device
US10505383B2 (en) 2017-09-19 2019-12-10 Rai Strategic Holdings, Inc. Intelligent charger for an aerosol delivery device
US11039645B2 (en) 2017-09-19 2021-06-22 Rai Strategic Holdings, Inc. Differential pressure sensor for an aerosol delivery device
US10660370B2 (en) 2017-10-12 2020-05-26 Rai Strategic Holdings, Inc. Aerosol delivery device including a control body, an atomizer body, and a cartridge and related methods
US20190116863A1 (en) 2017-10-24 2019-04-25 Rai Strategic Holdings, Inc. Method for formulating aerosol precursor for aerosol delivery device
US10806181B2 (en) 2017-12-08 2020-10-20 Rai Strategic Holdings, Inc. Quasi-resonant flyback converter for an induction-based aerosol delivery device
US10555558B2 (en) 2017-12-29 2020-02-11 Rai Strategic Holdings, Inc. Aerosol delivery device providing flavor control
US10813385B2 (en) 2018-03-09 2020-10-27 Rai Strategic Holdings, Inc. Buck regulator with operational amplifier feedback for an aerosol delivery device
US11206864B2 (en) 2018-03-26 2021-12-28 Rai Strategic Holdings, Inc. Aerosol delivery device providing flavor control
US10959459B2 (en) 2018-05-16 2021-03-30 Rai Strategic Holdings, Inc. Voltage regulator for an aerosol delivery device
US11094993B2 (en) 2018-08-10 2021-08-17 Rai Strategic Holdings, Inc. Charge circuitry for an aerosol delivery device
US10939707B2 (en) 2018-08-23 2021-03-09 Rai Strategic Holdings, Inc. Aerosol delivery device with segmented electrical heater
US11592793B2 (en) 2018-11-19 2023-02-28 Rai Strategic Holdings, Inc. Power control for an aerosol delivery device
US11614720B2 (en) 2018-11-19 2023-03-28 Rai Strategic Holdings, Inc. Temperature control in an aerosol delivery device
US11753750B2 (en) 2018-11-20 2023-09-12 R.J. Reynolds Tobacco Company Conductive aerosol generating composite substrate for aerosol source member
US11547816B2 (en) 2018-11-28 2023-01-10 Rai Strategic Holdings, Inc. Micropump for an aerosol delivery device
US11096419B2 (en) 2019-01-29 2021-08-24 Rai Strategic Holdings, Inc. Air pressure sensor for an aerosol delivery device
US20200245696A1 (en) 2019-02-06 2020-08-06 Rai Strategic Holdings, Inc. Buck-boost regulator circuit for an aerosol delivery device
US11456480B2 (en) 2019-02-07 2022-09-27 Rai Strategic Holdings, Inc. Non-inverting amplifier circuit for an aerosol delivery device
US20200278707A1 (en) 2019-03-01 2020-09-03 Rai Strategic Holdings, Inc. Temperature control circuitry for an aerosol delivery device
US11324249B2 (en) 2019-03-06 2022-05-10 R.J. Reynolds Tobacco Company Aerosol delivery device with nanocellulose substrate
CA3132789A1 (en) 2019-03-08 2020-09-17 Rai Strategic Holdings, Inc. Method for hydrolysis of lactic acid for aerosol delivery device
US11676438B2 (en) 2019-04-02 2023-06-13 Rai Strategic Holdings, Inc. Authentication and age verification for an aerosol delivery device
US11783395B2 (en) 2019-04-24 2023-10-10 Rai Strategic Holdings, Inc. Decentralized identity storage for tobacco products
US11690405B2 (en) 2019-04-25 2023-07-04 Rai Strategic Holdings, Inc. Artificial intelligence in an aerosol delivery device
US20200359703A1 (en) 2019-05-17 2020-11-19 Rai Strategic Holdings, Inc. Age verification with registered cartridges for an aerosol delivery device
US20210015171A1 (en) 2019-07-18 2021-01-21 R.J. Reynolds Tobacco Company Thermal energy absorbers for tobacco heating products
AU2020339828A1 (en) 2019-08-29 2022-03-24 Rai Strategic Holdings, Inc. Dual-chamber aerosol dispenser
GB201912686D0 (en) 2019-09-04 2019-10-16 Reown Pharma Inc Pharmaceutical composition
US11785991B2 (en) 2019-10-04 2023-10-17 Rai Strategic Holdings, Inc. Use of infrared temperature detection in an aerosol delivery device
US11470689B2 (en) 2019-10-25 2022-10-11 Rai Strategic Holdings, Inc. Soft switching in an aerosol delivery device
KR20220133203A (ko) 2019-12-30 2022-10-04 레이 스트라티직 홀딩스, 인크. 에어로졸 전달 장치용 심박수 모니터
US20210321655A1 (en) 2020-04-16 2021-10-21 R.J. Reynolds Tobacco Company Aerosol delivery device including a segregated substrate
US20210321674A1 (en) 2020-04-21 2021-10-21 Rai Strategic Holdings, Inc. Pressure-sensing user interface for an aerosol delivery device
US11839240B2 (en) 2020-04-29 2023-12-12 Rai Strategic Holdings, Inc. Piezo sensor for a power source
WO2021250516A1 (en) 2020-06-08 2021-12-16 Nicoventures Trading Limited Effervescent oral composition comprising an active ingredient
US11771132B2 (en) 2020-08-27 2023-10-03 Rai Strategic Holdings, Inc. Atomization nozzle for aerosol delivery device
US11771136B2 (en) 2020-09-28 2023-10-03 Rai Strategic Holdings, Inc. Aerosol delivery device
US11672761B2 (en) 2020-11-16 2023-06-13 Orcosa Inc. Rapidly infusing platform and compositions for therapeutic treatment in humans
US20220183389A1 (en) 2020-12-11 2022-06-16 Rai Strategic Holdings, Inc. Sleeve for smoking article
WO2022224197A1 (en) 2021-04-22 2022-10-27 Nicoventures Trading Limited Effervescent oral composition

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE45770B1 (en) * 1976-10-06 1982-11-17 Wyeth John & Brother Ltd Pharmaceutical dosage forms
DE3216869A1 (de) * 1982-05-03 1983-11-03 Schering AG, 1000 Berlin und 4709 Bergkamen Synergistische kombination mit zytostatischer wirkung
US5288497A (en) * 1985-05-01 1994-02-22 The University Of Utah Compositions of oral dissolvable medicaments
US5785989A (en) 1985-05-01 1998-07-28 University Utah Research Foundation Compositions and methods of manufacturing of oral dissolvable medicaments
NZ220599A (en) * 1986-06-16 1990-10-26 Merck & Co Inc Controlled release oral dosage formulation of carbidopa and levodopa
US4855326A (en) * 1987-04-20 1989-08-08 Fuisz Pharmaceutical Ltd. Rapidly dissoluble medicinal dosage unit and method of manufacture
GB8712073D0 (en) * 1987-05-21 1987-06-24 Smith Kline French Lab Medicament
US5234957A (en) * 1991-02-27 1993-08-10 Noven Pharmaceuticals, Inc. Compositions and methods for topical administration of pharmaceutically active agents
US5073374A (en) * 1988-11-30 1991-12-17 Schering Corporation Fast dissolving buccal tablet
US5079018A (en) * 1989-08-14 1992-01-07 Neophore Technologies, Inc. Freeze dry composition and method for oral administration of drugs, biologicals, nutrients and foodstuffs
ES2097155T3 (es) 1989-10-02 1997-04-01 Cima Labs Inc Forma de dosificacion efervescente y metodo de administracion.
GB9015095D0 (en) * 1990-07-09 1990-08-29 Smith Kline French Lab Therapeutic method
GB9216297D0 (en) * 1991-08-15 1992-09-16 Ici Plc Therapeutic agents
PL171158B1 (pl) * 1991-11-04 1997-03-28 Fuisz Technologies Ltd Kompozycja do dostarczania cieczy hydrofobowych o zdolnosci szybkiego ich uwalniani oraz sposób wytwarzania kompozycji do dostarczania cieczy hydrofobowych PL
NZ246091A (en) * 1991-12-24 1995-08-28 Yamanouchi Pharma Co Ltd Intrabuccally disintegrating preparation containing an active ingredient, agar, and lactose and/or mannitol
JP3069458B2 (ja) * 1992-01-29 2000-07-24 武田薬品工業株式会社 口腔内崩壊型錠剤およびその製造法
HUT75616A (en) * 1992-03-17 1997-05-28 Pfizer Method for prooucing porous delivery devices
US5298261A (en) 1992-04-20 1994-03-29 Oregon Freeze Dry, Inc. Rapidly distintegrating tablet
IL105553A (en) * 1992-05-06 1998-01-04 Janssen Pharmaceutica Inc Solid dosage forms consisting of a porous network of matrix that releases a substance that dissipates rapidly in water
CA2095776C (en) * 1992-05-12 2007-07-10 Richard C. Fuisz Rapidly dispersable compositions containing polydextrose
IL108366A (en) * 1993-03-11 1999-11-30 Taro Vit Ind Ltd Semi-solid pharmaceutical compounds and a device for their use
ATE241984T1 (de) * 1993-03-26 2003-06-15 Franciscus Wilhelmus He Merkus Pharmazeutische zusammensetzungen zur intranasalen verabreichung von apomorphin
DE4320678C2 (de) 1993-06-22 1996-04-11 Branko Dipl Ing Klasnic Vorrichtung zum Entfernen von Rechengut aus einer mit einer verunreinigten Flüssigkeit durchströmten Zulaufrinne, insbesondere von Kläranlagen
GB9421836D0 (en) * 1994-10-28 1994-12-14 Scherer Corp R P Process for preparing solid pharmaceutical dosage forms of hydrophobic substances
GB9517062D0 (en) 1995-08-18 1995-10-25 Scherer Ltd R P Pharmaceutical compositions

Also Published As

Publication number Publication date
RO119066B1 (ro) 2004-03-30
DK0850050T3 (da) 2000-10-16
EE9800050A (et) 1998-08-17
DE69610323T2 (de) 2001-02-22
PT850050E (pt) 2001-01-31
RU2189226C2 (ru) 2002-09-20
GR3034583T3 (en) 2001-01-31
EP0850050B1 (en) 2000-09-13
HUP9900183A3 (en) 1999-11-29
JPH11511162A (ja) 1999-09-28
CZ293129B6 (cs) 2004-02-18
AU6750996A (en) 1997-03-12
PL187718B1 (pl) 2004-09-30
ES2151672T3 (es) 2001-01-01
CZ45598A3 (cs) 1998-07-15
EP0850050A1 (en) 1998-07-01
SK19198A3 (en) 1998-09-09
PL324988A1 (en) 1998-07-06
NO313368B1 (no) 2002-09-23
MX9801305A (es) 1998-05-31
SK283597B6 (sk) 2003-10-07
BG102254A (en) 1998-10-30
GB9517062D0 (en) 1995-10-25
NZ315740A (en) 1999-06-29
CA2229597C (en) 2004-02-10
WO1997006786A1 (en) 1997-02-27
DE69610323D1 (de) 2000-10-19
NO980669D0 (no) 1998-02-17
BR9610424A (pt) 1999-03-30
AU709641B2 (en) 1999-09-02
ZA967032B (en) 1997-03-04
NO980669L (no) 1998-04-17
US6316027B1 (en) 2001-11-13
UA64700C2 (en) 2004-03-15
HU222197B1 (hu) 2003-05-28
ATE196249T1 (de) 2000-09-15
CA2229597A1 (en) 1997-02-27
HUP9900183A2 (hu) 1999-05-28
BG63188B1 (bg) 2001-06-29

Similar Documents

Publication Publication Date Title
EE03471B1 (et) Dopamiini agonisti sisaldav farmatseutiline kompositsioon, selle kasutamine ja valmistamismeetod, farmatseutiline produkt ja komplekt ning antatsiidi kasutamine
WO2001085257A3 (en) Opioid antagonist compositions and dosage forms
YU35893A (sh) Formulacije oksidona sa kontrolisanim otpuštanjem i njihova upotreba
KR930007439A (ko) 방출 조절형 제약 조성물
HUP0203451A2 (hu) Új, tuberkolózis elleni gyógyszerkészítmények és eljárás előállításukra
RU99117926A (ru) Лекарственные формы и способ лечения расстройства мужской эректильной функции
NO20000466D0 (no) Farmasoeytisk preparat for sure, lipofile forbindelser i form av en selvemulgerende formulering
HUP0204229A2 (hu) Orális opioid készítmények, eljárás az előállításukra és alkalmazásuk
CA2366702A1 (en) Compositions and methods for improved delivery of ionizable hydrophobic therapeutic agents
HUP0003405A2 (hu) Szabályozott hatóanyag-leadású, szublingvális vagy bukkális adagolású gyógyszerkészítmények
GB9901819D0 (en) Pharmaceutical compositions
IL179718A0 (en) Pharmaceutical composition containing irbesartan
AU780011B2 (en) Matrix tablet enabling the prolonged release of trimetazidine after administration by the oral route
MXPA03000548A (es) Combinacion novedosa de agonista (5-ht2) y antagonistas (5-ht6) de serotonina como formulacion farmaceutica.
WO2006053089A3 (en) Methods and formulations for making pharmaceutical compositions containing bupropion
BR0207872A (pt) Composto para liberar agentes ativos, composição, forma de unidade de dosagem e método de administração
CA2378613A1 (en) Selective iglur5 receptor antagonists for the treatment of migraine
EP1064966A3 (en) Combination of an 5HT1 receptor antagonist, caffeine and a cyclooxygenase-2 inhibitor for the treatment of migraine
MXPA05008921A (es) Formulaciones orales semisolidas para liberacion inmediata que comprenden un agente hidrofobo anticancer, un glicerido poliglicolisado y un vehiculo hidrofilo.
EP1064948A3 (en) Combination of an 5HT1 receptor antagonist, caffeine and a cyclooxygenase-2 inhibitor for the treatment of migraine
Zanin et al. Sex difference in sensitization to the locomotor effects of mazindol in rats
DK0483320T3 (da) Farmaceutiske sammensætninger med forlænget frigivelse til peroral indgivelse og fremgangsmåde til fremstilling deraf
YU70493A (sh) Stabilan vodeno rastvoran veterinarski preparat i postupak za njegovo dobijanje
MY102368A (en) Solid sustained-release composition
TH59782A3 (th) สารผสมของกาแลนแทมีนชนิดปลดปล่อยที่มีการควบคุม

Legal Events

Date Code Title Description
KB4A Valid patent at the end of a year

Effective date: 20021231

KB4A Valid patent at the end of a year

Effective date: 20031231

KB4A Valid patent at the end of a year

Effective date: 20041231

KB4A Valid patent at the end of a year

Effective date: 20051231

KB4A Valid patent at the end of a year

Effective date: 20061231

KB4A Valid patent at the end of a year

Effective date: 20071231

KB4A Valid patent at the end of a year

Effective date: 20081231

KB4A Valid patent at the end of a year

Effective date: 20091231

KB4A Valid patent at the end of a year

Effective date: 20101231

MM4A Lapsed by not paying the annual fees

Effective date: 20130816